相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1848
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- Researchers discovered that type I CRISPR-Cas systems in bacteria function not only as adaptive immune defenders but also as central regulators of embedded innate immunity genes, termed "CRISIS" systems. - More than twenty innate defense modules were found genomically embedded within CRISPR-Cas loci, kept under tight transcriptional control by small crRNA-like RNAs (crlRNAs). - When phages deploy anti-CRISPR (Acr) proteins to disable CRISPR-Cas, the repression is lifted, unleashing a burst of innate immunity that stops the phage at a fitness cost to the host. - The findings, published in Nature, could inform engineering of phage-resistant bacterial strains for industry and improve phage therapies targeting antibiotic-resistant pathogens.
- BrioHealth Solutions achieved a significant milestone with the 100th implantation of its investigational BrioVAD System across 34 US clinical trial sites since launching in November 2024. - The FDA granted conditional approval for the Brio4Kids Trial, marking the first expansion of the BrioVAD System evaluation into pediatric patients with advanced heart failure. - The compact pump design with thin driveline and lightweight components may address critical unmet needs in pediatric heart failure treatment where durable LVAD options remain limited. - Initial pediatric trial enrollment is expected to begin mid-2026 with preliminary data anticipated in the fourth quarter of 2026.
- Corvus Pharmaceuticals presented final Phase 1/1b data for soquelitinib at ASH 2025, showing median progression-free survival of 6.2 months and overall survival of 28.1 months in the 200 mg twice-daily cohort. - The ITK inhibitor demonstrated objective responses in 9 of 24 patients with 1-3 prior therapies, including 6 complete responses and 3 partial responses, with no dose-limiting toxicities observed. - The results support the ongoing registration Phase 3 trial in relapsed/refractory peripheral T cell lymphoma, addressing a significant unmet medical need where current treatments yield poor outcomes. - Soquelitinib's novel mechanism affects T cell differentiation by promoting Th1 cells while blocking Th2 and Th17 development, with potential applications beyond oncology in immune and inflammatory diseases.
- A randomized controlled trial of 108 people with HIV-associated lipohypertrophy found that weekly Ozempic treatment for 32 weeks reversed biological age by an average of 3.1 years. - The study used epigenetic clocks to measure biological aging, showing the most pronounced anti-aging effects in the inflammatory system and brain, where aging was delayed by almost 5 years. - Researchers believe the anti-aging effects stem from semaglutide's ability to improve fat distribution and reduce inflammation, both major drivers of cellular aging. - While the study focused on a specific patient population, the biological pathways affected by semaglutide suggest similar anti-aging effects could occur in other populations.
- Children and young adults previously covered by Medicaid are losing access to essential medications for conditions like asthma, depression, ADHD, epilepsy, and schizophrenia following pandemic-era coverage protections ending. - States with the largest drops in Medicaid enrollment (17% or more) showed greater disruption in medication therapy, with patients more likely to stop filling prescriptions or resort to paying cash. - Researchers warn that medication interruptions can lead to disease flare-ups, potentially increasing school and work absenteeism among affected youth.
- Approximately 10% of U.S. internal medicine physicians report experiencing high levels of burnout across all three domains: emotional exhaustion, detachment, and feeling their efforts don't make a difference. - Burnout prevalence was significantly higher among physicians in the Western U.S. (15.4%) compared to those in the Northeast (8.8%), Midwest (8.5%), and South (6.6%). - No significant differences in burnout rates were found between practice settings (community, VA, academic) or between primary care physicians and hospitalists, suggesting systemic rather than context-specific causes.
- Over 75% of dementia patients are unaware of their diagnosis despite having access to primary care, with higher unawareness rates among Mexican-Americans (85%) compared to white patients (68%). - A separate study found that 75% of low-income seniors at community health centers had undiagnosed cognitive issues, with Black patients more than twice as likely as whites to have unrecognized cognitive impairment. - Medical experts emphasize that timely dementia diagnosis is crucial for proper treatment, support services, and potential interventions that could slow disease progression.
